Ironic Biotech: Revolutionizing Iron Supplementation
April 6, 2024, 3:35 am
Ironic Biotech
Total raised: $1.09M
A Swedish startup, Ironic Biotech, has raised €1 million to combat iron deficiency and anemia with plant-derived proteins that promise no side effects. The company aims to help 2 billion individuals worldwide suffering from iron deficiency by providing a breakthrough solution for effective iron supplementation.
Ironic Biotech, a biotech startup from Sweden, has secured €1 million in pre-seed funding to address the global health crisis of iron deficiency and anemia. The funding, led by Helsinki’s Nordic Foodtech VC, will support the development of a new generation of plant-derived proteins rich in bioavailable iron, produced through precision fermentation.
The proteins developed by Ironic Biotech offer a promising solution for individuals struggling with iron deficiency, as they have no side effects commonly associated with traditional iron supplements. With absorption rates comparable to meat-based iron, these proteins provide an effective alternative for consumers with inadequate dietary iron intake.
Dr. Nélida Leiva Eriksson, the founder of Ironic Biotech, emphasizes the importance of addressing iron deficiency, which affects up to 25% of the global population and can lead to severe exhaustion, fatigue, heart palpitations, learning disabilities, and anemia. As red meat consumption declines and more individuals adopt plant-based diets, the need for effective iron supplementation becomes increasingly critical.
Existing iron supplements often come with unwanted side effects, such as digestive issues and nausea, due to poor absorption rates. Ironic Biotech’s patented compounds offer a breakthrough in iron supplementation, with no side effects and neutral flavor profiles, making them ideal for incorporation into food and supplements.
The funding raised by Ironic Biotech will be used to drive further research and development, expand the company’s patent portfolio, and optimize the production process. The team is also seeking collaborations with partners in the food and supplement industry to bring their innovative solution to a wider audience.
With a mission to empower individuals, particularly women who are more susceptible to iron deficiency, Ironic Biotech is committed to providing a solution that truly works. By revolutionizing iron supplementation with plant-derived proteins, the company aims to bridge the performance gap caused by iron deficiency and improve the overall health and well-being of millions worldwide.
Ironic Biotech, a biotech startup from Sweden, has secured €1 million in pre-seed funding to address the global health crisis of iron deficiency and anemia. The funding, led by Helsinki’s Nordic Foodtech VC, will support the development of a new generation of plant-derived proteins rich in bioavailable iron, produced through precision fermentation.
The proteins developed by Ironic Biotech offer a promising solution for individuals struggling with iron deficiency, as they have no side effects commonly associated with traditional iron supplements. With absorption rates comparable to meat-based iron, these proteins provide an effective alternative for consumers with inadequate dietary iron intake.
Dr. Nélida Leiva Eriksson, the founder of Ironic Biotech, emphasizes the importance of addressing iron deficiency, which affects up to 25% of the global population and can lead to severe exhaustion, fatigue, heart palpitations, learning disabilities, and anemia. As red meat consumption declines and more individuals adopt plant-based diets, the need for effective iron supplementation becomes increasingly critical.
Existing iron supplements often come with unwanted side effects, such as digestive issues and nausea, due to poor absorption rates. Ironic Biotech’s patented compounds offer a breakthrough in iron supplementation, with no side effects and neutral flavor profiles, making them ideal for incorporation into food and supplements.
The funding raised by Ironic Biotech will be used to drive further research and development, expand the company’s patent portfolio, and optimize the production process. The team is also seeking collaborations with partners in the food and supplement industry to bring their innovative solution to a wider audience.
With a mission to empower individuals, particularly women who are more susceptible to iron deficiency, Ironic Biotech is committed to providing a solution that truly works. By revolutionizing iron supplementation with plant-derived proteins, the company aims to bridge the performance gap caused by iron deficiency and improve the overall health and well-being of millions worldwide.